Hasil Pencarian - Gerald A Soff

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Romiplostim in chemotherapy‐induced thrombocytopenia: A review of the literature

    Romiplostim in chemotherapy‐induced thrombocytopenia: A review of the literature oleh Gerald A. Soff, Hanny Al‐Samkari, Avi Leader, Melissa Eisen, Hossam Saad

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use

    Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use oleh Cy R. Wilkins, Jocelyn Ortiz, Leah J. Gilbert, Shen Yin, Jodi V. Mones, Rekha Parameswaran, Simon Mantha, Gerald A. Soff

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia.

    Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia. oleh Gerald A Soff, Isabelle Ray-Coquard, Luis J Marfil Rivera, Jon Fryzek, Megan Mullins, Lauren C Bylsma, Joseph K Park

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial

    Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial oleh Jodi V. Mones, Michael B. Streiff, Alok A. Khorana, Gemma A. Bendheim, C. V. Damaraju, Peter Wildgoose, Paul Burton, Hanno Riess, Gerald A. Soff

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI Trial

    Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI Trial oleh Alok A. Khorana, Mairéad G. McNamara, Ajay K. Kakkar, Michael B. Streiff, Hanno Riess, Ujjwala Vijapurkar, Simrati Kaul, Peter Wildgoose, Gerald A. Soff

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience

    Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience oleh Gerald A. Soff, Jodi Mones, Cy Wilkins, Sean Devlin, Eva Haegler‐Laube, Jonathan Wills, Debra M. Sarasohn, Krishna Juluru, Michael Singer, Yimei Miao, Jeanette Batista, Simon Mantha

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: